Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
A Novel Therapy Discovered for the Treatment of Relapsed or Refractory Multiple Myeloma
Janssen discovered novel therapy, Teclistamab for the treatment of relapsed or refractory multiple myeloma. Teclistamab is an off-the-shelf, T-cell redirecting, bispecific antibody which targets both B-Cell Maturation Antigen (BCMA) and CD3 receptors
Novel Therapy, Sotorasib, Discovered for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Amgen novel therapy Sotorasib discovered for the treatment of patients with Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients with KRAS G12C Mutation. Sotorasib, an investigational small molecule that selectively and irreversibly targets KRASG12C, is developed for the treatment of advanced or metastatic NSCLC in patient population.
Novel HER2-Targeted Bispecific Antibody Zanidatamab Developed for Patients with Biliary Tract Cancer
Zanidatamab, a bispecific antibody developed for the treatment of patients with previously-treated HER2 gene-amplified Biliary Tract Cancer (BTC). Zanidatamab is built on Zymeworks’ Azymetric™ platform binding two non-overlapping epitopes of HER2 known asbiparatopic binding.
Novel Elecsys Growth Differentiation Factor-15 (GDF-15) Assay Discovered for Cancer Treatment
Elecsys® GDF-15 assay discovered as a Companion Diagnostic (CDx) for the treatment of cancer. It helps in finding patients suitable for innovative treatment addressing unintentional weight loss in cancer patients. Elecsys GDF-15 a quantitative serologic which uses the format of sandwich test
Novel APL-106 (uproleselan) Discovered for the Treatment of Acute Myeloid Leukemia
Apollomics, Inc discovered novel APL-106 (uproleselan) for the treatment of relapsed/refractory Acute Myeloid Leukemia (AML) in China. AML is an aggressive disease and relapsed/refractory having an extremely poor prognosis in patients.
Novel Cancer Immunotherapy Tiragolumab Discovered for the Treatment of Non-Small Cell Lung Cancer
Tiragolumab, a novel cancer immunotherapy discovered for the treatment of metastatic Non-small Cell Lung Cancer (NSCLC). Tiragolumab, is the first anti-TIGIT molecule introduced to bind with TIGIT, a protein receptor on immune cells. It functions as an immune amplifier, by improving the body’s immune response. By combining with TIGIT
New Xolair® Treats Severe Chronic Rhinosinusitis with Nasal Polyps
Novartis has discovered a new Xolair® indication for the treatment of severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) for adults. Xolair® (omalizumab), is the first discovered treatment option for CRSwNP which specifically targets and blocks the growth
A Novel Oral Therapy Discovered to Treat Adult Patients with Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
Blueprint Medicines Corporation discovered GAVRETO™ for the treatment of adult patients with metastatic Rearranged during Transfection (RET) fusion-positive Non-small Cell Lung Cancer (NSCLC).
Novel Therapy, Toripalimab, Developed to Treat Nasopharyngeal Carcinoma
Toripalimab, a novel therapy has been discovered for the treatment of nasopharyngeal carcinoma by Junshi Biosciences. Toripalimab, the first anti-PD-1 monoclonal antibody developed for the treatment of Nasopharyngeal carcinoma
Plinabulin Developed to Prevent Chemotherapy-Induced Neutropenia
BeyondSpring Inc develops breakthrough therapy Plinabulin, for chemotherapy-induced neutropenia indication for patients with cancer. Plinabulin is a first-in-class differentiated immune and stem cell modulator.
